Start-up
UroQuant GmbH
Transforming Cancer Diagnostics
About UroQuant
Using protein biomarkers, UROQUANT will revolutionise diagnostics. The first product, UROQUANT BC for diagnosing bladder cancer directly from urine will be established as novel gold standard for routine cancer patient care.
- Focus : Manufacturer
- Industry : Diagnostics
Product portfolio of UroQuant
Here you will find UroQuant GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
